venBio Global Strategic Fund II L.P.
CIK 1634632 · View on SEC EDGAR ↗
Insider
Activist
First SEC filing: Jan. 24, 2018 · Latest: Feb. 4, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 2 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
2 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 25, 2018 | YARW | P | 265,000 | $17.00 | $4,505,000 | 265,000 Direct | — | Acquired | -99.9% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 29, 2018 | YARW | Series C Preferred Stock | Common Stock (1,196,552) | — | — | 3,227,700 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 24, 2018 | YARW | Series C Preferred Stock→ Common Stock (1,196,552) | 1,196,552 | Direct |